Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

CEO questions revolving doors approval

  • Dansk
  • Nederlands
  • English
  • Suomi
  • Français
  • Deutsch
  • Ελληνικά
  • Italiano
  • Bokmål
  • Polski
  • Portuguese
  • Română
  • Slovenščina
  • Español
  • Svenska
 

Open letter

Citizen groups say no to CETA

On the eve of the Canada–EU summit more than hundred organizations on both sides of the Atlantic have issued a statement which strongly opposes the EU-Canada Comprehensive Economic and Trade Agreement (CETA) because it will enrich multinational corporations at the expense of citizens’ rights. CEO is one of the signatories.
Campaign groups today called on members of the European Parliament to back citizens' demands for improved rules to prohibit the cultivation of genetically modified (GM) crops. A letter signed by five environment, consumers and farmers groups was sent to all members of the parliament's environment committee, which will debate this controversial issue later in the week.
The position of Chief Scientific Adviser to the President of the European Commission is problematic, concentrating too much influence in one person and undermining other Commission research and assessment processes. We ask Mr Juncker, the new President of the European Commission, to scrap the position.
Read our response to the EU ombudsman in her inquiry into the commission's handling of the revolving door.
A crusade for big business-friendly deregulation, waged during José Manuel Barroso's Presidency of the European Commission, shows no signs of stopping. This neoliberal push to weaken or block new legislation appears likely to expand with Jean-Claude Juncker's new Commission team.
Our correspondence with Pr. Anne Glover, the current Chief Scientific Adviser to the President of the European Commission (CSA), on her role in the European Commission's review of endocrine disrupting chemicals shows how the very existence of her position was used by business-friendly interests to convey key messages to the top of the European Commission's hierarchy, playing a determining role in the massive delay now inflicted to the European Commission's handling of this important public health regulation. We ask that the CSA position is not renewed in the new Juncker Commission.
Will EFSA become more transparent, and to lobbyists or scientists? After its public consultation on its draft transparency policy, the Authority must now choose.
Corporate Europe Observatory (CEO) today criticised the plenary vote of MEPs to approve the Jean-Claude Juncker Commission.

Corporate Europe Forum